Zota Health Care expands DavaIndia network by 264 stores in Q1FY27

Zota Health Care expanded its DavaIndia retail pharmacy network by opening 264 stores during Q1FY27, increasing the total operational count to 2,825. The company closed 18 stores during the period, resulting in a net addition of 246 stores from the previous base of 2,579 as on March 31, 2026.

Store Expansion Breakdown

The expansion comprised a mix of Company-Owned Company-Operated (COCO) and Franchise-Owned Franchise-Operated (FOFO) models. The following table details the movement in store count during the quarter:

Store Type	Total stores as on 31-03-2026	Opened during Q1FY27	Closed during Q1FY27	Total Stores as on 30-06-2026
COCO	1656	201	02	1855
FOFO	923	63	16	970
Total stores	2579	264	18	2825

COCO stores are managed by M/s Davaindia Health Mart Limited, a wholly-owned subsidiary of the company. The total store figure represents operative stores after considering all closures and relocations.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.55%	+3.89%	+27.84%	-5.37%	+31.92%	+558.50%

Zota Health Care Limited has acquired 10,00,000 equity shares of its wholly-owned subsidiary, Curexis Ventures Private Limited, for ₹2 crore through a subscription to a rights issue. The transaction, completed on June 22, 2026, was executed at a price of ₹20 per share, including a premium of ₹10 per share. This strategic investment is intended to support the expansion of SKIA retail pharmacy stores and address the working capital requirements of Curexis.

The acquisition does not constitute a related party transaction and was conducted on an arm's length basis, with no interest held by the promoter or group companies in Curexis. Following this investment, Curexis continues to remain a wholly-owned subsidiary of Zota Health Care Limited . No specific governmental or regulatory approvals were required for the completion of this transaction.

Curexis Ventures Private Limited operates in the pharmaceutical industry and is engaged in drug manufacturing, development, and marketing. The entity runs retail pharmacy stores under the brand name "SKIA", offering a range of pharmaceutical, nutraceutical, cosmetic, ayurvedic, and over-the-counter products. The company was incorporated on February 25, 2025, and is domiciled in India.

Financial details for Curexis indicate a turnover of ₹1.18 Lakhs for the financial year 2025-26, with a total paid-up share capital of ₹1 Lakh. The entity reported no turnover in the previous financial year, FY 2024-25, and turnover data was not available for FY 2023-24.

The following table outlines the key financial and operational details of the acquisition:

Particulars	Details
Target Entity	Curexis Ventures Private Limited
Shares Acquired	10,00,000 equity shares
Cost of Acquisition	₹2 crore
Price per Share	₹20 (including premium of ₹10)
Date of Acquisition	June 22, 2026
Turnover (FY 2025-26)	₹1.18 Lakhs
Paid-up Share Capital	₹1 Lakh